Viemed Healthcare, Inc. (NASDAQ:VMD) Sees Large Decrease in Short Interest

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 340,000 shares, a decline of 14.6% from the March 31st total of 398,300 shares. Approximately 1.0% of the shares of the company are sold short. Based on an average daily trading volume, of 112,600 shares, the short-interest ratio is presently 3.0 days.

Institutional Trading of Viemed Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the business. R Squared Ltd acquired a new position in Viemed Healthcare in the fourth quarter valued at $41,000. Corton Capital Inc. purchased a new position in shares of Viemed Healthcare during the fourth quarter worth about $82,000. EntryPoint Capital LLC acquired a new position in Viemed Healthcare in the 4th quarter valued at about $92,000. Prudential Financial Inc. purchased a new stake in Viemed Healthcare during the 4th quarter valued at approximately $93,000. Finally, Man Group plc acquired a new stake in Viemed Healthcare during the 4th quarter worth approximately $95,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $7.37 on Monday. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The stock has a market cap of $291.29 million, a P/E ratio of 27.30 and a beta of 1.64. The stock has a 50 day moving average of $7.15 and a two-hundred day moving average of $7.99. Viemed Healthcare has a twelve month low of $6.21 and a twelve month high of $9.81.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.